| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 02/27/2007 | US7183275 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 02/27/2007 | US7183272 Crystal forms of oxcarbazepine and processes for their preparation |
| 02/27/2007 | US7183271 Vasopressin active materials; antidiabetic agents; diuretics; bioavailability |
| 02/27/2007 | US7183264 Such as ethyl-1-(9-((4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxy-methyl)oxolan-2-yl)-6 -aminopurin-2-yl)pyrazole-4-carboxylate; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 02/27/2007 | US7183261 Galactosylceramide analogs, and β-glucocerebrosidase activators, external skin preparations and method of activating β-glucocerebrosidase using the analogs |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183254 Diagnosis, hormone replacement therapy for HIV positive females, gene therapy; metabolic disorders; antidiabetic, anticholesterol, hypoglycemic agents |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7182963 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 02/27/2007 | US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| 02/27/2007 | CA2168517C Substituted thiophenylsulfonylureas and -thioureas processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/22/2007 | WO2007021020A1 Capsinoid containing composition |
| 02/22/2007 | WO2007020965A1 Method of inhibiting function of cytosolic protein by single chain antibody and use thereof |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020884A1 BIFIDOBACTERIUM OR LACTIC ACID BACTERIUM HAVING EFFECT OF PREVENTING INFECTION VIA β-DEFENSIN AND FOOD/PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
| 02/22/2007 | WO2007020873A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 02/22/2007 | WO2007020337A1 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same |
| 02/22/2007 | WO2006002119A3 Kinase inhibitors for treating cancers |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070043116 Method for preventing and/or treating neurodegenerative diseases |
| 02/22/2007 | US20070043114 Nerve regeneration promoters |
| 02/22/2007 | US20070043087 Compounds exhibiting thrombopoietin receptor agonism |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043069 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043026 Dopamine receptor modulators as antipsychotic agents |
| 02/22/2007 | US20070043018 2"-Hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042964 Compositions and methods for modulating connexin hemichannels |
| 02/22/2007 | US20070042963 Therapeutic peptides |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042937 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042374 drug screening; obesity, diabetes mellitus, impaired glucose tolerance, arteriosclerosis, hypertension or hyperlipemia |
| 02/22/2007 | US20070042056 Anti-stress agent |
| 02/22/2007 | US20070041996 Aromatase activating agent |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618212A1 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1754706A1 SELECTIVE INHIBITORS AGAINST Cdk4 AND Cdk6 HAVING AMINOTHIAZOLE SKELETON |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1754702A1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 02/21/2007 | EP1754480A2 Compositions comprising phospholipase c inhibitors and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1754472A2 Compositions for treatment of disorders associated with chlamydia |
| 02/21/2007 | EP1753766A1 Tetraazabenzo(e)azulene derivatives and analogs thereof |
| 02/21/2007 | EP1753449A2 Methods and compositions for control of fetal growth via modulation of relaxin |
| 02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
| 02/21/2007 | EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 02/21/2007 | EP1358156B1 Benz(g) indoles and their use as spla2 inhibitors |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP1290006B1 Combinatorial production of nucleotide and nucleoside (XITP) analogues |
| 02/21/2007 | EP1255749B1 Tyrosine derivatives with anti-leukotriene activity |
| 02/21/2007 | EP1230922B9 Agents for promoting fattening of animals and method of promoting fattening |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1135374B9 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/21/2007 | EP1133474B1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918119A Bicycloester derivative |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917775A Feed additive for laying hens and feed containing the additive |
| 02/21/2007 | CN1916020A Peptide antiangiogenic drugs |
| 02/21/2007 | CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 02/21/2007 | CN1915986A High purified tanshinone óÄA sodium sulfonate, fabricating method, and preparation |
| 02/21/2007 | CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 02/21/2007 | CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders |
| 02/21/2007 | CN1915968A Neutral-cationic lipid for nucleic acid and drug delivery |
| 02/21/2007 | CN1915424A Acellular pertussis vaccines and methods of preparation thereof |
| 02/21/2007 | CN1915410A Medication for sticking on acupuncture point for treating disease of spontaneous perspiration in type of insufficiency of the lung-qi, and preparation method |